Plenvu

Chronic Pain, Catarrh, Acute Bronchitis + 8 more

Treatment

3 FDA approvals

20 Active Studies for Plenvu

What is Plenvu

Sodium ascorbate

The Generic name of this drug

Hemocyte Plus

is the brand name

image of different drug pills on a surface

Plenvu Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Hemocyte Plus

Sodium ascorbate

2002

6

Approved as Treatment by the FDA

Sodium ascorbate, also known as Hemocyte Plus, is approved by the FDA for 3 uses including Nutritional supplementation and Vitamin supplementation .

Nutritional supplementation

Vitamin supplementation

Used in combination with Sodium ascorbate for Vitamin supplementation

Vitamin supplementation therapy

Used in combination with Sodium ascorbate for Vitamin supplementation therapy

When to interrupt dosage

The amount of Plenvu is contingent upon the established disorder, including Throat irritation, Catarrh and Influenza. The dosage may vary as per the procedure of administration (e.g. Oral or Capsule - Oral) specified in the table underneath.

Condition

Dosage

Administration

Vitamin supplementation therapy

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Catarrh

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Fever

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Acute Bronchitis

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Throat irritation

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Influenza

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Vitamin supplementation

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Nutritional supplementation

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Hoarseness

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Airway secretion clearance therapy

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Chronic Pain

60.0 mg, , 250.0 mg, 500.0 mg, 50.0 mg, 4700.0 mg, 20.0 mg, 10.0 mg, 100.0 mg, 85.0 mg, 200.0 mg, 5.9 mg/mL, 36.0 mg, 500.0 mg/mL, 120.0 mg, 48110.0 mg, 5900.0 mg, 393.0 mg, 37.5 mg, 394.7 mg, 67.5 mg, 197.0 mg, 337.5 mg, 84.5 mg, 56.0 mg, 45.0 mg, 140.0 mg, 280.0 mg, 343.0 mg, 855.0 mg, 112.5 mg, 575.0 mg, 79.0 mg, 171.0 mg, 159.0 mg, 300.0 mg, 121.4 mg, 227.0 mg, 143.3 mg, 242.72 mg, 78.8 mg, 483.0 mg, 169.0 mg, 277.5 mg, 114.0 mg, 242.7 mg, 59.0 mg, 56.24 mg, 57.0 mg, 566.0 mg, 121.36 mg, 338.0 mg, 72.0 mg, 187.0 mg, 300.0 mg/mL, 250.0 mg/mL, 0.8888 mg/mg, 0.01 mg/mg, 50.0 mg/mL, 35.0 mg/mL

, Tablet, Tablet - Oral, Oral, Liquid - Intramuscular; Intravenous, Liquid, Intramuscular; Intravenous, Powder, Powder - Oral, Wafer, Wafer - Oral, Intravenous, Solution - Intravenous, Solution, Powder, for solution - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule - Oral, Capsule, Kit, Tablet, chewable, Tablet, chewable - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated - Oral, Tablet, film coated, Powder, for solution, Lozenge, Lozenge - Oral, Liquid - Oral, Kit - Oral, Solution - Oral

Warnings

There are 20 known major drug interactions with Plenvu.

Common Plenvu Drug Interactions

Drug Name

Risk Level

Description

Alloin

Minor

The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Alloin.

Calcium polycarbophil

Minor

The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Calcium polycarbophil.

Chlorpropamide

Minor

Sodium ascorbate may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.

Frangula purshiana bark

Minor

The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Frangula purshiana bark.

Konjac mannan

Minor

The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Konjac mannan.

image of a doctor in a lab doing drug, clinical research

Plenvu Novel Uses: Which Conditions Have a Clinical Trial Featuring Plenvu?

249 active studies are presently evaluating the potential of Plenvu to provide Vitamin supplementation therapy, Chronic Pain relief and Hoarseness relief for certain conditions.

Condition

Clinical Trials

Trial Phases

Chronic Pain

130 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1

Vitamin supplementation

0 Actively Recruiting

Acute Bronchitis

7 Actively Recruiting

Phase 4, Not Applicable, Phase 3, Early Phase 1

Airway secretion clearance therapy

0 Actively Recruiting

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Nutritional supplementation

0 Actively Recruiting

Hoarseness

0 Actively Recruiting

Catarrh

0 Actively Recruiting

Influenza

29 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3

Throat irritation

0 Actively Recruiting

Vitamin supplementation therapy

0 Actively Recruiting

Plenvu Reviews: What are patients saying about Plenvu?

5

Patient Review

9/22/2022

Plenvu for Emptying of the Bowel

Plenvu is by far the best bowel cleanse product I have tried. You only have to drink the solution two times and it doesn't leave you feeling dried out like other products do. The taste is also not bad at all - if you've ever had oral MRI imaging solution, this is much easier to stomach. I would highly recommend it to anyone who needs a good cleansing product.

5

Patient Review

10/21/2022

Plenvu for Emptying of the Bowel

I mixed the two doses with clear Gatorlyte, cherry lime flavor. The taste was not bad. I'm 45 years old and it went well for me.

4.3

Patient Review

11/9/2022

Plenvu for Emptying of the Bowel

I was very anxious about this prep, but it honestly wasn't as bad as I thought it would be. I sipped on the prep and then immediately drank water after. Just paced myself and used a straw so I wouldn't gulp it down too fast.

4

Patient Review

9/25/2022

Plenvu for Emptying of the Bowel

I was really pleased with how this bowel prep went. I followed the instructions to a T and everything happened as it should have. The second dose was tough, but that's to be expected. Overall, I would definitely recommend this product.

3.7

Patient Review

10/7/2022

Plenvu for Emptying of the Bowel

The taste is better than most preps, but it's still not great. I followed the low residual diet as prescribed, but there was still fecal matter in my bowels. The prep wasn't good enough.

3

Patient Review

9/21/2022

Plenvu for Emptying of the Bowel

This medication works but is very harsh. The taste is incredibly unpleasant, and it made me want to vomit. I'll be looking for something else next time.

2.7

Patient Review

10/17/2022

Plenvu for Emptying of the Bowel

I was violently ill after taking the second dose of this medication.

2

Patient Review

11/2/2022

Plenvu for Emptying of the Bowel

The first dose was gross tasting but I managed to keep it down. The second dose, however, led to me vomiting it up immediately. I'm not sure if it was successful or not, but if not then this entire process has been a waste of time. I much prefer the old-school one shot method to this stuff.

1.7

Patient Review

10/26/2022

Plenvu for Emptying of the Bowel

Vomited after the second dose. Didn't clean me out at all, unfortunately. This was my fifth colonoscopy and I'll have to go through it again because of this product's ineffectiveness.

1

Patient Review

9/23/2022

Plenvu for Emptying of the Bowel

This was an absolutely terrible experience. The taste is unbearable, and I ended up regurgitating after only drinking half the second dose. Do not recommend this to anyone.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about plenvu

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Plenvu a good colonoscopy prep?

"The average rating for Plenvu as a treatment for Bowel Preparation is 4.7 out of 10 from a total of 317 ratings."

Answered by AI

What is Plenvu medication?

"PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride for oral solution) is a prescription medication that adults take to clean the colon before a colonoscopy."

Answered by AI

How fast should you drink Plenvu?

"slowly drink the mixture over the course of 30 minutes."

Answered by AI

Do you have to drink Plenvu slowly?

"Make sure to drink all bowel preparation doses slowly, using small sips over at least 30 minutes. You can also take a break from drinking the preparation if needed, but continue once the nausea and/or vomiting has subsided."

Answered by AI

Clinical Trials for Plenvu

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Have you considered Plenvu clinical trials?

We made a collection of clinical trials featuring Plenvu, we think they might fit your search criteria.
Go to Trials

Have you considered Plenvu clinical trials?

We made a collection of clinical trials featuring Plenvu, we think they might fit your search criteria.
Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN

The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).

Phase 4
Waitlist Available

Vanderbilt University Medical Center

Danial Shams, MD

Image of Baylor College of Medicine/Texas Children's Hospital in Austin, United States.

Guided Imagery Therapy for Abdominal Pain

7 - 12
All Sexes
Austin, TX

Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.

Waitlist Available
Has No Placebo

Baylor College of Medicine/Texas Children's Hospital (+1 Sites)

Have you considered Plenvu clinical trials?

We made a collection of clinical trials featuring Plenvu, we think they might fit your search criteria.
Go to Trials